🔗 Share this article

An underground market for unlicensed slimming drugs is being driven by social media fitness personalities and sellers on communication apps, according to recent findings.

Experimental Drug Acquiring Popularity Via Social Media

The experimental drug, which is still in clinical trials, is being promoted by online personalities for its alleged fat-burning properties. Viewers are encouraged to message these accounts directly for source information, while also obtaining promotional offers.

Thriving Commerce on Social Networks

Additionally, a robust market exists on messaging services, where communities with numerous of participants share “before and after” photos, injection guides and assertions of next-day British shipping. Vendors market the drug there before directing customers to WhatsApp for transactions.

Learning About The Experimental Drug

Retatrutide is an investigational injectable developed by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could assist individuals reduce up to a quarter of their total weight. Referred to as the “triple G”, the drug is being promoted digitally as the successor to Ozempic.

Medical Professionals Voice Worries

However, physicians and pharmacists have warned that the sale of what is still an unlicensed drug in the United Kingdom is a cause for concern and could result in individuals administering products of unknown origin.

Some professionals stated the demand for retatrutide could be connected to the rising cost of licensed weight loss treatments such as Mounjaro.

Regulatory Position and Enforcement

Marketing the unapproved drug on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unapproved drug that must not be marketed or distributed for human use under the Human Medicines Regulations 2012.

Some content creators try to circumvent the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but advertising and distribution can still breach pharmaceutical, advertising, and customer laws, potentially leading to penalties, prosecution or prison.

Platform Response and Content Elimination

According to TikTok, the platform has removed problematic content and prohibited related hashtags and query recommendations. The organization stated it was committed to maintaining the service secure and investing in enhancing compliance measures.

Online Trading Operations

Research also discovered communities with up to 9,000 participants selling the experimental drug using the platform's integrated discovery tool, which functions like a online catalog. Typing “retatrutide” instantly displays channels with thousands of members, populated with photos of weight loss, glowing reviews and detailed instructions for mixing or injecting at residence.

Within moments of entering one community, a seller shared WhatsApp details, where the majority of purchases take place. The seller provided an guidebook and guaranteed delivery within two days. When questioned whether the substance was genuine, one seller responded: “You can’t be sure.” Another shared a photo of a alleged testing documentation. Not one asked about weight, medical conditions or past usage.

Product Information and Costs

Within these groups, posts show dark colored packages with Royal Mail labels, claiming to include new batches. One communication read: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, mixed at residence with purified liquid, or pre-filled injectors usually priced at 160 pounds for 20mg. When asked how much time a pen should be used, sellers give conflicting answers varying between a several days to “depends on your body”.

Platform Oversight and Safety Actions

A spokesperson for the messaging service said it regularly moderated harmful content on its service including material that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“People are injecting materials they cannot confirm. Although the research behind this drug is sound, these online products may not contain what they advertise,” stated a pharmacy expert, the head of pharmacy at Chemist4U.

Dr Crystal Wyllie of an online medical service linked the surge in interest to current cost increases for authorized weight-loss drugs such as Mounjaro. “With costs increasing, patients are turning to social media. But counterfeit treatments are highly risky. You can’t be certain what’s contained or whether the conditions they were made in was clean,” she said.

Her team has already encountered patients harmed by personal administration from unverified sources. “We recognize the disappointment, but purchasing from messaging apps or WhatsApp is taking chances with your health,” stated Wyllie. “These substances could be contaminated or incorrectly dosed.”

Manufacturer Position

A spokesperson from Eli Lilly stated the substance was in phase 3 research studies and had not been reviewed or authorized by any regulatory agency globally. “Therefore at this time no one can sell [it] for personal consumption,” they said, adding that any item “falsely representing itself as a Lilly investigational product not yet approved … may subject patients to possibly serious medical dangers”.